About Mylan

Mylan is a global healthcare company focused on making high quality medicines available to everyone who needs them.  Our broad and diverse portfolio of more than 7,500 marketed products is available to customers of all types including retail and pharmacy establishments, wholesalers, governments, institutions and physicians.

A History of Doing What’s Right

We began in 1961 as a company dedicated to helping people in small West Virginia towns and rural communities gain access to affordable medicine. Today, we remain dedicated to the same mission, but we do it for the world.

  1. 0

    Increasing Generic Utilisation

    We’re actively educating governments around the world about the role generic medicines play in affordable health care and access to medicine.
  2. 0

    Driving Biosimilar Access

    Biosimilars are generic equivalents of biologics—expensive medicines for diseases like cancer, multiple sclerosis, rheumatoid arthritis and diabetes. We promote effective biosimilar approval pathways that drive interchangeability, maximise patient access to more affordable, high quality biologics and reduce health care spending.
  • Our Values

    What sets us apart? Innovation, Integrity, Reliability, Service and Teamwork. Living our values is how we can work to provide 7 billion people access to high quality medicine.
    Discover how our values define us
  • Mylan Voices

    • Robert J Coury
      Executive Chairman
      "We have one global quality standard because we know where our priorities are. It all starts and ends with you."
    • Heather Bresch
      Chief Executive Officer
      "Our mission is to provide 7 billion people access to high quality medicine.
      We are determined to put the care back in healthcare."
    • Rajiv Mallik
      "Setting new standards in health care is a promise that Mylan keeps every day."
  • Global Manufacturing

    Mylan has a global network of 47 operations facilities

    • Oral solid dose manufacturing capacity: >75 billion
    • Injectables manufacturing capacity: >500M units
    • Complex products manufacturing capacity: 1.3B units
    • API capacity: >4,800KL
  • Questions?

    Get more information on our products, services and Mylan Global Center locations.
    Contact us

  • Business Opportunities

    Do you have an opportunity or a collaboration idea?
    Partner with us

Last Updated  30/10/2018